Three quarters of a mile from civilization

Views, analysis & commentary - essentially on venture capital & pharmaceutical industry

Wednesday, October 9, 2013

Isn't 'Syndicate' a worrisome term on an online crowd-funding platform?

›
A recent article by Lora Kolodny on Venture Capital Dispatch raises some interesting aspects on how VCs perceive the impact of likes of A...
Wednesday, September 25, 2013

End of the day it's all about the Benjamins', impressive TVPIs not withstanding!

›
In a wake-up call of sorts, Super LP Chris Douvos cautions GP universe that end of the day it's ' all about the Benjamins ', i...

We are all just prisoners here, of our own device!

›
Where does this notion that every mild ache or pain might be the harbinger of something particularly nasty, or even fatal, come from? asks ...
Thursday, September 12, 2013

Ambrosia for food, Palm-top engagement, Iterative decision making – A preview into evolving expectations of the healthcare consumer

›
Understanding consumer preferences has always been of paramount importance in most product segments. Within the pharmaceutical domain howe...
2 comments:
Wednesday, August 28, 2013

Isn't re-coding the organizational DNA viable only for smaller set-ups?

›
Bruce Booth makes some really radical suggestions to altering the way a big-pharma R&D set-up could work, primarily by way of re-codi...
Tuesday, July 30, 2013

Peak-Oil 2020 just got itself a mega top-up & the globe can look forward to balmier climes :-)

›
One of those small diversions from my routine - below's the comment I posted on a Linkedin article " OilBoom 2.0 – An American Dr...
Monday, July 22, 2013

The start-up investing winds, they are a-Changing OR are they?

›
In his latest, 'SuperLP' Chris Douvos  writes about the fears of an impending VC apocalypse....., okay to start with, in silicon va...
‹
›
Home
View web version
Powered by Blogger.